Annexon Inc (ANNX)

NASDAQ
5.62
+0.24(+4.46%)
  • Volume:
    88,644
  • Day's Range:
    5.42 - 5.64
  • 52 wk Range:
    2.06 - 23.61

ANNX Overview

Prev. Close
5.38
Day's Range
5.42-5.64
Revenue
-
Open
5.48
52 wk Range
2.06-23.61
EPS
-3.78
Volume
88,644
Market Cap
264.75M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
444,061
P/E Ratio
-1.38
Beta
0.664
1-Year Change
-74.74%
Shares Outstanding
47,617,740
Next Earnings Date
Nov 21, 2022
What is your sentiment on Annexon?
or
Vote to see community's results!

Annexon Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Annexon Inc Company Profile

Annexon Inc Company Profile

Employees
61

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company’s C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration. Its product candidates include ANX005, a monoclonal antibody, which is in Phase II/III clinical trials to treat patients with guillain- barré syndrome; Phase II trial in patients with warm autoimmune hemolytic anemia; and Phase II clinical trial for Huntington’s disease and amyotrophic lateral sclerosis. The company is also developing ANX009 that is in Phase Ib trial in patients with lupus nephritis; and ANX007, which is in Phase II clinical trials to treat patients with geographic atrophy. In addition, it develops ANX105, an investigational monoclonal antibody targeting neurodegenerative indications; and ANX1502, an investigational oral small molecule for the treatment of certain autoimmune indications. The company was incorporated in 2011 and is headquartered in Brisbane, California.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuySell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
  • is there anybody?
    0